{"id":"cit-013-medium-dose","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, I do not have enough information to provide a deeper explanation of the mechanism of CIT-013.","oneSentence":"CIT-013 is a medium dose of a drug that targets a specific molecular pathway.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T02:30:58.420Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 2 clinical trial for unspecified indication"}]},"trialDetails":[{"nctId":"NCT06567470","phase":"PHASE2","title":"A Study With CIT-013 in RA Patients","status":"RECRUITING","sponsor":"Citryll BV","startDate":"2025-07-29","conditions":"Rheumatoid Arthritis","enrollment":88},{"nctId":"NCT06993233","phase":"PHASE2","title":"A Study With CIT-013 in HS Patients","status":"RECRUITING","sponsor":"Citryll BV","startDate":"2025-10-31","conditions":"Hidradenitis Suppurativa (HS)","enrollment":96}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CIT-013 medium dose","genericName":"CIT-013 medium dose","companyName":"Citryll BV","companyId":"citryll-bv","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CIT-013 is a medium dose of a drug that targets a specific molecular pathway. Used for Phase 2 clinical trial for unspecified indication.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}